ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $216,000 | -27.0% | 3,956 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $296,000 | +10.4% | 4,169 | +16.6% | 0.00% | 0.0% |
| Q3 2021 | $268,000 | -3.9% | 3,575 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $279,000 | -38.1% | 3,575 | -35.3% | 0.00% | -50.0% |
| Q1 2021 | $451,000 | -19.3% | 5,524 | -18.3% | 0.00% | 0.0% |
| Q4 2020 | $559,000 | -9.0% | 6,764 | -28.5% | 0.00% | -33.3% |
| Q3 2020 | $614,000 | -4.8% | 9,454 | -9.2% | 0.00% | 0.0% |
| Q2 2020 | $645,000 | -6.2% | 10,416 | -2.9% | 0.00% | -25.0% |
| Q1 2020 | $688,000 | -1.4% | 10,731 | +6.5% | 0.00% | +33.3% |
| Q4 2019 | $698,000 | +35.5% | 10,080 | +24.0% | 0.00% | 0.0% |
| Q3 2019 | $515,000 | +9.6% | 8,132 | +10.0% | 0.00% | +50.0% |
| Q2 2019 | $470,000 | +42.4% | 7,392 | +30.9% | 0.00% | 0.0% |
| Q1 2019 | $330,000 | +10.0% | 5,647 | +15.9% | 0.00% | 0.0% |
| Q4 2018 | $300,000 | -9.4% | 4,871 | +14.7% | 0.00% | 0.0% |
| Q3 2018 | $331,000 | +56.1% | 4,246 | +35.0% | 0.00% | +100.0% |
| Q2 2018 | $212,000 | -32.3% | 3,145 | -42.6% | 0.00% | -50.0% |
| Q1 2018 | $313,000 | – | 5,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |